Keimari Mendez, MD
Obstetrics & Gynecology · San Juan, PRNPI 1780884908
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 5 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 4 manufacturers reported payments, led by Merck at 44.2% of the total. Reporting peaked in 2023 at $121 and has fallen 79.4% since, to $25 in 2025. That places this record below the midpoint for obstetrics & gynecology clinicians in PR, where the typical reported total is $470.
Across 5 payments — averaging $59.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$131
- Roche Diagnostics Corporation$121
- Hologic Sales And Service, LLC$25
- Sage Therapeutics, LLC$19
Across 18 payments — averaging $3775.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$52K
- AbbVie$14K
- Organon$2K
What the payments were for
- Food & beverage$296100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 2 | $131 |
| Roche Diagnostics Corporation | 1 | $121 |
| Hologic Sales And Service, LLC | 1 | $25 |
| Sage Therapeutics, LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$296 in reported general payments places this provider in the 35th percentile of 333 obstetrics & gynecology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Megestrol Acetate | 19 | $595 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 26 | $504 |
| Alendronate Sodium | 41 | $406 |
| Medroxyprogesterone Acetate | 22 | $225 |
| Metronidazole | 13 | $168 |
| Pantoprazole Sodium | 12 | $82 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in San Juan
- Erika Benabe-GonzalezSan Juan$24K
- Carlos FonsecaSan Juan$8K
- Olga PereiraSan Juan$7K
- Eduardo Muniz VelezSan Juan$7K
- Soan Cruz-OrtizSan Juan$5K
- Janice Soto-MoralesSan Juan$5K
- Gabriella Rivera OrtizSan Juan$4K
- Nicolas Casellas CastilloSan Juan$3K
- Maria ZweigSan Juan$2K
- Natalia Cardenas SuarezSan Juan$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.